Soleil Boughton - 23 Feb 2026 Form 4 Insider Report for Hims & Hers Health, Inc. (HIMS)

Role: Chief Legal Officer
Signature: /s/ Kimberly Mather, Attorney-in-Fact for Soleil Boughton
Issuer symbol: HIMS
Transactions as of: 23 Feb 2026
Net transactions value: $0
Form type: 4
Filing time: 25 Feb 2026, 16:16:33 UTC
Previous filing: 16 Dec 2025
Next filing: 02 Mar 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Boughton Soleil	Chief Legal Officer	2269 CHESTNUT STREET, #523, SAN FRANCISCO	/s/ Kimberly Mather, Attorney-in-Fact for Soleil Boughton	25 Feb 2026	0001837817

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	HIMS	Class A Common Stock	Award	$0	+273,794	+159%	$0.000000	445,623	23 Feb 2026	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents performance-based restricted stock units (PRSUs) earned pursuant to a previously granted award. Each PRSU represents a contingent right to receive one share of the Company's Class A common stock. The Compensation Committee of the Company's Board of Directors certified that the performance criteria established in connection with this award has been met as of February 23, 2026. In accordance with the award's terms, the shares underlying the PRSUs will be delivered to the Reporting Person on or about March 15, 2026.

Content

Represents performance-based restricted stock units (PRSUs) earned pursuant to a previously granted award. Each PRSU represents a contingent right to receive one share of the Company's Class A common stock. The Compensation Committee of the Company's Board of Directors certified that the performance criteria established in connection with this award has been met as of February 23, 2026. In accordance with the award's terms, the shares underlying the PRSUs will be delivered to the Reporting Person on or about March 15, 2026.